Teladoc Health, Inc. (NYSE:TDOC) Stock Rated "Hold" by Wall Street Brokerages

Key Points

• Wall Street’s consensus rating is “Hold”: Of 19 analysts covering Teladoc, 12 rate the stock Hold, five Buy and two Sell. The average one-year price target is $8.40.
• Analysts have made mixed target changes: Bank of America raised its target to $11.50 and Oppenheimer to $10, while Truist cut its target to $8.
• Latest quarterly results beat estimates: Teladoc reported a loss of $0.15 per share and revenue of $605.1 million, topping forecasts for both, though revenue fell 3.4% year over year.

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) has received a consensus rating of "Hold" from the nineteen research firms that are currently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, twelve have assigned a hold recommendation and five have given a buy recommendation to the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $8.40.

A number of equities analysts recently weighed in on the stock. Bank of America boosted their price target on shares of Teladoc Health from $10.50 to $11.50 in a research report on Thursday, October 29th. Oppenheimer upped their price objective on shares of Teladoc Health from $7.00 to $10.00 and gave the company an "outperform" rating in a research note on Monday, November 2nd. Stifel Nicolaus increased their price objective on shares of Teladoc Health from $5.50 to $6.50 and gave the company a "hold" rating in a report on Thursday, October 29th. Truist Financial decreased their target price on shares of Teladoc Health from $9.00 to $8.00 and set a "hold" rating on the stock in a research note on Friday, August 14th. Finally, Wells Fargo & Company raised their target price on shares of Teladoc Health from $6.00 to $8.00 and gave the stock an "equal weight" rating in a research note on Thursday.

Insider Activity

In related news, CEO Charles III sold 17,805 shares of the stock in a transaction that occurred on Friday, September 11th. The stock was sold at an average price of $6.10, for a total value of $108,610.50. Following the completion of the sale, the chief executive officer owned 465,535 shares of the company's stock, valued at approximately $2,839,763.50. This trade represents a 3.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.70% of the stock is owned by company insiders.

Hedge Funds Weigh In On Teladoc Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of Teladoc Health during the 2nd quarter worth $1,447,000. Counterpoint Mutual Funds LLC boosted its position in shares of Teladoc Health by 1,017.4% during the 3rd quarter. Counterpoint Mutual Funds LLC now owns 1,650,165 shares of the health services provider's stock valued at $9,571,000 after acquiring an additional 1,502,488 shares during the last quarter. Monaco Asset Management SAM acquired a new position in shares of Teladoc Health during the 2nd quarter valued at about $26,864,000. ABS Investment Management LLC acquired a new position in shares of Teladoc Health during the 2nd quarter valued at about $1,513,154. Finally, ABS Direct Equity Fund LLC purchased a new stake in shares of Teladoc Health in the second quarter valued at about $1,513,000. Institutional investors and hedge funds own 76.82% of the company's stock.

Teladoc Health Stock Down 6.5%

Shares of TDOC opened at $8.79 on Friday. Teladoc Health has a 52-week low of $4.40 and a 52-week high of $9.89. The firm's fifty day moving average is $6.51 and its two-hundred day moving average is $6.54. The stock has a market cap of $1.60 billion, a PE ratio of -10.23 and a beta of 2.00.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its earnings results on Wednesday, October 28th. The health services provider reported ($0.15) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.22) by $0.07. The business had revenue of $605.10 million during the quarter, compared to analyst estimates of $588.14 million. Teladoc Health had a negative net margin of 6.27% and a negative return on equity of 11.63%. The company's revenue for the quarter was down 3.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.28) earnings per share. As a group, research analysts anticipate that Teladoc Health will post -0.86 earnings per share for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services and technology designed to connect patients with medical professionals remotely. Through its digital platforms, the company supports a range of healthcare needs, including general medical consultations, mental health services, specialty care, and ongoing management of chronic conditions.

Its offerings include telehealth visits with physicians and other licensed providers, behavioral health services through BetterHelp, and chronic care programs that use digital tools and clinical support to help people manage conditions such as diabetes and hypertension.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.